Geriatrics News

Individuals treated for Alzheimer’s disease had lower all-cause health care costs and lower mortality rates, compared with untreated individuals, according to data presented at the Alzheimer’s Association International Conference.

A 5-year, projected $10.8 million award from the National Institute on Aging will help launch the Coordinating Center for Genetics and Genomics of Alzheimer’s Disease, a collaboration between the University of Pennsylvania, Boston University, Case Western Reserve University, Columbia University, University of Miami and the University of Indiana.

ATLANTA — David Mischoulon, MD, PhD, of Massachusetts General Hospital, discusses an upcoming study assessing vitamin D and omega-3 fatty acids for the prevention of depression and improvement of mood in older adults.

ATLANTA — Charles Reynolds, III, MD, of the University of Pittsburgh School of Medicine and Medical Center, provides simple strategies that were similarly effective for depression prevention in white and black older adults at-risk for depression.

The National Institute of Aging recently granted $14.5 million to researchers conducting a study on a dietary intervention, the Mediterranean-DASH Intervention for Neurodegenerative Delay, for Alzheimer’s disease.

The Alzheimer’s Association recently announced a $4.3 million research grant for a new phase of the Dominantly Inherited Alzheimer’s Network Trials Unit study called Next Generation.

The American Psychiatric Association recently published new recommendations for the use of antipsychotics for agitation or psychosis in individuals with dementia.

Although citalopram appeared to reduce delusions, anxiety and irritability among individuals with Alzheimer’s disease, researchers expressed concern regarding cognitive and cardiac side effects of the treatment.

The NIH has awarded a $3.6 million grant to Luciano D’Adamio, MD, PhD, of Albert Einstein College of Medicine, to continue his research on how amyloid precursor protein is processed in the brain.

Set-shifting performance predicted response to aripiprazole augmentation among older adults with treatment-resistant depression, according to recent findings.